📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. (2024)

First Author: Askanase AD

Attributed to: MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/lupus-2023-001124

PubMed Identifier: 38777595

Publication URI: http://europepmc.org/abstract/MED/38777595

Type: Journal Article/Review

Volume: 11

Parent Publication: Lupus science & medicine

Issue: 1

ISSN: 2053-8790